Medasense Biometrics
Noninvasive Pain-monitoring Solutions
Health Tech & Life Sciences
Private
Company Overview
Generating analyst summary…
Log in to access full profile ›Company Intelligence Q&A
- What is Medasense Biometrics' primary product?
- Medasense Biometrics' flagship product is the PMD-200, which incorporates the NOL index. This platform uses artificial intelligence and a proprietary noninvasive sensor system to objectively monitor and quantify a patient's pain response.
- When was Medasense Biometrics founded?
- Medasense Biometrics was founded in June 2008.
- Which investors participated in Medasense Biometrics' September 2020 funding round?
- In September 2020, Medasense Biometrics received funding from Sabadell Asabys VC and OTV.
- What was a key regulatory milestone for Medasense Biometrics?
- In February 2023, the FDA authorized the marketing of Medasense's NOL technology for measuring pain in anesthetized patients.
- Which investors participated in Medasense Biometrics' November 2015 funding round?
- In November 2015, Medasense Biometrics received funding from OTV and Baxter Ventures.